Why we must remove barriers to trade to achieve vaccine equity (Step #3)
To put an end to the pandemic, industry was tasked with manufacturing and supplying billions of COVID-19 vaccines, starting from zero. This monumental task is on its way to being achieved, with 11 billion doses forecast for the end of 2021[1]—enough for the world’s adult population, according to the World Bank. However, trade restrictions, amongst...
Read moreIFPMA Statement at WTO-WHO High Level Dialogue “Expanding COVID-19 Vaccine Manufacture to Promote Equitable Access” – Session title: Looking ahead
21 July 2021 – Today, as stated by Dr Ngozi Okonjo-Iweala, Director General of the World Trade Organization, we are on course to produce 11 billion doses of COVID-19 vaccines by the end of this year, which is sufficient to vaccinate the world’s whole adult population. Now, the issue is how these vaccines are going...
Read moreCOVID-19 Vaccine Manufacturing in Africa: Identifying a Pathway Forward
Increasing manufacturing capacity for COVID-19 vaccines is one of the biggest challenges we need to address in our common goal to bring this pandemic to an end. Science has delivered not one but several vaccines that are safe and effective and the goal is ensure fair and equitable delivery to vaccines to those who most...
Read moreInnovation for a healthier world: How the research-based vaccine manufacturers are contributing to the Decade of vaccines action plan
Read moreGlobal regulators and coalition of pharma and vaccine manufacturing associations come together to discuss COVID-19 pandemic response
On 7 July 2021, the International Coalition of Medicines Regulatory Authorities (ICMRA) is hosting a (virtual) workshop titled ‘Enabling Manufacturing Capacity in the COVID-19 Pandemic’ [link] with representatives from the leading association bodies representing biotech firms, developing and industrialized countries vaccine manufacturers, as well as innovative biopharmaceutical, generic and biosimilar companies. This first workshop with...
Read moreGlobal Biopharma CEO/Top Executives COVID-19 Media Briefing – COVID-19 therapeutics-3 September 2020 (Video)
Read moreGlobal Biopharma CEO/Top Executives Virtual Press Briefing – 30 April 2020 (Video)
Read morePharma industry updates advice on engaging with healthcare professionals as countries emerge from COVID-19 lockdown
Geneva, 28 May 2020: As countries lift lockdown restrictions, the international pharma industry body, IFPMA, provides its members with ethical considerations on when and how to resume in-person meetings with healthcare practitioners and other stakeholders within the healthcare system. During the COVID-19 pandemic, biopharmaceutical companies proactively interrupted face-to-face interactions between their representatives and physicians, in...
Read moreFive steps to urgently advance COVID-19 vaccine equity
Innovative vaccine manufacturers and biotech companies are at the forefront of the global effort to develop and manufacture COVID-19 vaccines.
Read moreThe evolution of the SARS-COV-2 virus is a stark reminder that research and innovation must continue (Step #5)
Developing COVID-19 vaccines in less than a year was a monumental achievement – but to improve the efficacy, manufacture and distribution of vaccines and combat emerging variants, governments, regulators and research scientists must work together to drive further innovation. Imagine if scientists invented a COVID-19 vaccine that can be given orally, without the need of...
Read more